These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 5110141)

  • 1. N,N-dimethylated indoleamines in blood.
    Narasimhachari N; Heller B; Spaide J; Haskovec L; Meltzer H; Strahilevitz M; Himwich HE
    Biol Psychiatry; 1971; 3(1):21-3. PubMed ID: 5110141
    [No Abstract]   [Full Text] [Related]  

  • 2. N-dimethylated indoleamines in blood of acute schizophrenics.
    Heller B; Narasimhachari N; Spaide J; Haskovec L; Himwich HE
    Experientia; 1970 May; 26(5):503-4. PubMed ID: 5444830
    [No Abstract]   [Full Text] [Related]  

  • 3. Blood dimethyltryptamine concentrations in psychotic disorders.
    Lipinski JF; Mandel LR; Ahn HS; Vanden Heuvel WJ; Walker RW
    Biol Psychiatry; 1974 Aug; 9(1):89-91. PubMed ID: 4616726
    [No Abstract]   [Full Text] [Related]  

  • 4. A dimethyltryptamine-forming enzyme in human blood.
    Wyatt RJ; Saavedra JM; Axelrod J
    Am J Psychiatry; 1973 Jul; 130(7):754-60. PubMed ID: 4514540
    [No Abstract]   [Full Text] [Related]  

  • 5. Gas chromatographic-mass spectrometric isotope dilution determination of N,N-dimethyltryptamine concentrations in normals and psychiatric patients.
    Wyatt RJ; Mandel LR; Ahn HS; Walker RW; Vanden Heuvel WJ
    Psychopharmacologia; 1973 Jul; 31(3):265-70. PubMed ID: 4517484
    [No Abstract]   [Full Text] [Related]  

  • 6. Gas chromatographic-mass spectrometric identification of urinary bufotenin and dimethyltryptamine in drug-free chronic schizophrenic patients.
    Narasimhachari N; Baumann P; Pak HS; Carpenter WT; Zocchi AF; Hokanson L; Fujimori M; Himwich HE
    Biol Psychiatry; 1974 Jun; 8(3):293-305. PubMed ID: 4527813
    [No Abstract]   [Full Text] [Related]  

  • 7. Detection of psychotomimetic N,N-dimethylated indoleamines in the urine of four schizophrenic patients.
    Tanimukai H; Ginther R; Spaide J; Bueno JR; Himwich HE
    Br J Psychiatry; 1970 Oct; 117(539):421-30. PubMed ID: 5312352
    [No Abstract]   [Full Text] [Related]  

  • 8. Indoleamines in blood plasma of schizophrenics a critical study with sensitive and selective methods.
    Axelsson S; Nordgren L
    Life Sci; 1974 Apr; 14(7):1261-70. PubMed ID: 4823639
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies of drug-free schizophrenics and controls.
    Narasimhachari N; Avalos J; Fujimori M; Himwich HE
    Biol Psychiatry; 1973 Dec; 5(3):311-8. PubMed ID: 4513564
    [No Abstract]   [Full Text] [Related]  

  • 10. The dimethyltryptamine-forming enzyme in blood platelets: a study in monozygotic twins discordant for schizophrenia.
    Wyatt RJ; Saavedra JM; Belmaker R; Cohen S; Pollin W
    Am J Psychiatry; 1973 Dec; 130(12):1359-61. PubMed ID: 4518712
    [No Abstract]   [Full Text] [Related]  

  • 11. [Endogenous hallucinogens].
    Kanabus P; Frindt-Zajaczkowska A
    Psychiatr Pol; 1974; 8(2):197-202. PubMed ID: 4830327
    [No Abstract]   [Full Text] [Related]  

  • 12. Gas chromatographic-mass spectrometric isotope dilution assay for N,N-dimethyltryptamine in human plasma.
    Walker RW; Ahn HS; Albers-Schönberg G; Mandel LR; Vandenheuvel WJ
    Biochem Med; 1973 Aug; 8(1):105-13. PubMed ID: 4582927
    [No Abstract]   [Full Text] [Related]  

  • 13. [Presence of N-methylated and N-acetylated indolamines in urine from patients with schizophrenia and from normal individuals].
    Faurbye A; Pind K
    Ugeskr Laeger; 1971 Jul; 133(28):1356-8. PubMed ID: 5566986
    [No Abstract]   [Full Text] [Related]  

  • 14. Urinary studies of schizophrenics and controls.
    Narasimhachari N; Heller B; Spaide J; Haskovec L; Fujimori M; Tabushi K; Himwich HE
    Biol Psychiatry; 1971; 3(1):9-20. PubMed ID: 4398666
    [No Abstract]   [Full Text] [Related]  

  • 15. A possible mechanism for the antischizophrenic action of chlorpromazine: inhibition of the formation of dimethyltryptamine by chlorpromazine metabolites.
    Narasimhachari N; Lin RL
    Res Commun Chem Pathol Pharmacol; 1974 Jun; 8(2):341-51. PubMed ID: 4527612
    [No Abstract]   [Full Text] [Related]  

  • 16. [N,N-dimethyltryptamine and bufotenin in the urine of patients with chronic and acute schizophrenic psychoses].
    Rosengarten H; Szemis A; Piotrowski A; Romaszewska K; Matsumoto H; Stencka K; Jus A
    Psychiatr Pol; 1970; 4(5):519-21. PubMed ID: 5483205
    [No Abstract]   [Full Text] [Related]  

  • 17. Native use and occurence of N,N-Dimethyltryptamine in the leaves of Banisteriopsis rusbyana.
    Marderosian AH; Pinkley HV; Dobbins MF
    Am J Pharm Sci Support Public Health; 1968; 140(5):137-47. PubMed ID: 5698438
    [No Abstract]   [Full Text] [Related]  

  • 18. Gas chromatographic-mass spectrometric identification of N:N-dimethyltryptamine in urine samples from drug-free chronic schizophrenic patients and its quantitation by the technique of single (selective) ion monitoring.
    Narasimhachari N; Himwich HE
    Biochem Biophys Res Commun; 1973 Dec; 55(4):1064-71. PubMed ID: 4520847
    [No Abstract]   [Full Text] [Related]  

  • 19. [Determination of guanidinoacetic acid concentration in serum and cerebrospinal fluid].
    Szilágyi KA
    Acta Physiol Acad Sci Hung; 1970; 38(4):405-10. PubMed ID: 5521451
    [No Abstract]   [Full Text] [Related]  

  • 20. [Changes of the blood protein picture in neurotic and schizophrenic patients treated with metaminodiazepoxide by parenteral administration].
    Cassarino P; Di Venti F; Falsaperla A
    Acta Neurol (Napoli); 1967; 22(5):655-68. PubMed ID: 5608894
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.